These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 31686319)
41. Editing Plant Genomes: a new era of crop improvement. Petolino JF; Srivastava V; Daniell H Plant Biotechnol J; 2016 Feb; 14(2):435-6. PubMed ID: 26817702 [No Abstract] [Full Text] [Related]
42. Delivery of CRISPR/Cas9 by Novel Strategies for Gene Therapy. Wang L; Zheng W; Liu S; Li B; Jiang X Chembiochem; 2019 Mar; 20(5):634-643. PubMed ID: 30393919 [TBL] [Abstract][Full Text] [Related]
43. Point: Treating Human Genetic Disease One Base Pair at a Time: The Benefits of Gene Editing. Katsanis N Clin Chem; 2018 Mar; 64(3):486-488. PubMed ID: 29490998 [No Abstract] [Full Text] [Related]
44. [Genome editing technology and its application in forage legumes]. Liu H; Meng Y; Niu L; Lin H Sheng Wu Gong Cheng Xue Bao; 2017 Oct; 33(10):1733-1743. PubMed ID: 29082721 [TBL] [Abstract][Full Text] [Related]
48. CRISPR/Cas9 Gene Editing: From Basic Mechanisms to Improved Strategies for Enhanced Genome Engineering In Vivo. Salsman J; Masson JY; Orthwein A; Dellaire G Curr Gene Ther; 2017; 17(4):263-274. PubMed ID: 29173169 [TBL] [Abstract][Full Text] [Related]
49. Recent trends in CRISPR-Cas system: genome, epigenome, and transcriptome editing and CRISPR delivery systems. Bae T; Hur JW; Kim D; Hur JK Genes Genomics; 2019 Aug; 41(8):871-877. PubMed ID: 31119685 [TBL] [Abstract][Full Text] [Related]
50. Genome editing in the mammalian brain using the CRISPR-Cas system. Nishiyama J Neurosci Res; 2019 Apr; 141():4-12. PubMed ID: 30076877 [TBL] [Abstract][Full Text] [Related]
51. In search of: Suggesting a course of action for the scientific community to research potential impacts of heritable gene editing on the maternal carrier. Gravelle R Semin Perinatol; 2018 Dec; 42(8):522-524. PubMed ID: 30482592 [TBL] [Abstract][Full Text] [Related]
52. Targeted Gene Manipulation in Plants Using the CRISPR/Cas Technology. Zhang D; Li Z; Li JF J Genet Genomics; 2016 May; 43(5):251-62. PubMed ID: 27165865 [TBL] [Abstract][Full Text] [Related]
53. Recent advance on genome editing for therapy of β-hemoglobinopathies. Liu JW; Hong T; Qin X; Liang YM; Zhang P Yi Chuan; 2018 Feb; 40(2):95-103. PubMed ID: 29428902 [TBL] [Abstract][Full Text] [Related]
54. CRISPR-Cas9: a promising tool for gene editing on induced pluripotent stem cells. Kim EJ; Kang KH; Ju JH Korean J Intern Med; 2017 Jan; 32(1):42-61. PubMed ID: 28049282 [TBL] [Abstract][Full Text] [Related]